NUVL
NUVL
NASDAQ · Biotechnology

Nuvalent Inc-A

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$123.96
+0.02 (+0.02%)
As of Aug 8, 9:47 PM ET ·
Analyst Consensus
Hold
23
Analysts
High
Coverage
Buy 8 35%
Hold 15 65%
Sell 0 0%
Price Target
Analyst Price Target -73.2% upside
Low Target $20.12
Average Target $33.28
High Target $44.46
Current Price $123.96
Current
$123.96
Target
$33.28
$20.12 $33.28 avg $44.46
Scenario Analysis
Bear Case
$20.12
-83.8%
Low target
Base Case
$33.28
-73.2%
Avg target
Bull Case
$44.46
+-64.1%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$123.99
0.0% from high
52-Week Low
$71.13
+74.3% from low
50-Day SMA
$103.76
+19.5% vs SMA
200-Day SMA
$88.57
+40.0% vs SMA
RSI (14)
53.7
Neutral
Target vs 52W High
$33.28
-73.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%